The global pneumococcal vaccine market is anticipated to grow at a significant CAGR during the forecast period. The major factor for the growth of the market includes the increasing efforts to curb pneumonia among children in developed countries. Whereas, in the developing countries, the increasing spending on infrastructure and rising awareness towards vaccines, are the factors, which are expected to fuel the market growth during the forecasted period.
Get Free Sample link @ https://www.omrglobal.com/request-sample/pneumococcal-vaccine-market-share
According to the report by Jon Hopkins, in 2019, 5 million children died before reaching the age of 5 years, out of which around 25% of children died due to pneumonia or diarrhoea. The developing countries in Asia and Africa contribute to around 70% of the global death burden of children due to pneumonia. GAVI (the vaccine alliance) is working towards vaccinating these children who are living in emerging economies. For many countries including the UK, Canada, Russia, Norway, Bill Gates and Melinda Gates Foundation had contributed around $1.5 billion towards the program. By the end of 2018, more than 183 million children were given shot of the vaccine against pneumococcal.
Some of the key global market players include Pfizer Inc., Sanofi SA, GlaxoSmithKline PLC, Serum Institute of India Pvt. Ltd., Merck & Co., Inc., Walvax Biotechnology Co., Ltd., CSL Ltd., and Astellas Pharma Inc. In June 2020, the Serum Institute of India started supplying vaccines for $2 as compared to $3.5 per dose earlier. The company had agreed to provide 10 million doses per year to the countries which are supported by GAVI for the next 10 years.
Full report of Pneumococcal Vaccine Market available @ https://www.omrglobal.com/industry-reports/pneumococcal-vaccine-market-share
Market Coverage
- Segment Covered-
o By Vaccine Type
o By Distribution Channel
o By Type
o By Age Group
Competitive Landscape – Pfizer Inc., Sanofi SA, GlaxoSmithKline PLC, Serum Institute of India Pvt. Ltd., Merck & Co., Inc., Walvax Biotechnology Co., Ltd., CSL Ltd., among others
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominates the market in base year?
- Which segment and region will project fastest growth in the market?
- How COVID-19 impacted the market?
o Recovery Timeline
o Deviation from pre-COVID forecast
o Most affected region and segment
- Who is the leader in the market?
- How players are addressing challenges to sustain growth?
- Where is the investment opportunity?
Global Pneumococcal Vaccine Market by Segment
o By Vaccine Type
- Pneumococcal Conjugate Vaccine (PCV13)
- Pneumococcal Polysaccharide Vaccine (PPSV23)
o By Distribution Channel
- Public
- Private
o By Type
- Branded
- Generic
o By Age Group
- Children
- Adult
Reasons to Buying From us –
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/pneumococcal-vaccine-market-share
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.